Wellfully 将来の成長

Future 基準チェック /06

We currently don't have sufficient analyst coverage to forecast growth and revenue for Wellfully.

主要情報

n/a

収益成長率

n/a

EPS成長率

Pharmaceuticals 収益成長	54.6%
収益成長率	n/a
将来の株主資本利益率	n/a
アナリストカバレッジ	None
最終更新日	n/a

今後の成長に関する最新情報

更新なし

Recent updates

このセクションでは通常、投資家が会社の利益創出能力を理解する一助となるよう、プロのアナリストのコンセンサス予想に基づく収益と利益の成長予測を提示する。しかし、Wellfully は十分な過去のデータを提供しておらず、アナリストの予測もないため、過去のデータを外挿したり、アナリストの予測を使用しても、その将来の収益を確実に算出することはできません。

シンプリー・ウォール・ストリートがカバーする企業の97%は過去の財務データを持っているため、これはかなり稀な状況です。

業績と収益の成長予測

ASX:WFL - アナリストの将来予測と過去の財務データ ( )AUD Millions
日付	収益	収益	フリー・キャッシュフロー	営業活動によるキャッシュ	平均アナリスト数
12/31/2022	2	-8	-6	-6	N/A
9/30/2022	2	-8	-7	-7	N/A
6/30/2022	3	-7	-8	-8	N/A
3/31/2022	2	-7	-7	-7	N/A
12/31/2021	1	-7	-7	-6	N/A
9/30/2021	1	-7	-6	-6	N/A
6/30/2021	1	-6	-5	-5	N/A
3/31/2021	1	-6	-5	-5	N/A
12/31/2020	1	-6	-5	-5	N/A
9/30/2020	1	-5	-4	-4	N/A
6/30/2020	1	-4	-3	-3	N/A
3/31/2020	2	-3	-2	-2	N/A
12/31/2019	3	-2	-2	-2	N/A
9/30/2019	3	-2	-2	-2	N/A
6/30/2019	3	-2	-2	-2	N/A
3/31/2019	2	-2	-2	-2	N/A
12/31/2018	2	-2	-2	-2	N/A
9/30/2018	2	-2	-2	-2	N/A
6/30/2018	2	-2	-1	-1	N/A
3/31/2018	2	-1	-1	-1	N/A
12/31/2017	2	-1	-1	-1	N/A
9/30/2017	2	-2	-1	-1	N/A
6/30/2017	2	-3	-2	-2	N/A
3/31/2017	2	-4	-2	-2	N/A
12/31/2016	2	-5	-3	-2	N/A
9/30/2016	2	-4	N/A	-2	N/A
6/30/2016	2	-4	N/A	-2	N/A
3/31/2016	2	-3	N/A	-2	N/A
12/31/2015	2	-3	N/A	-3	N/A
9/30/2015	2	-3	N/A	-2	N/A
6/30/2015	2	-2	N/A	-2	N/A
3/31/2015	1	-2	N/A	-2	N/A
12/31/2014	1	-2	N/A	-2	N/A
9/30/2014	1	-2	N/A	-2	N/A
6/30/2014	1	-2	N/A	-2	N/A
3/31/2014	1	-2	N/A	-1	N/A
12/31/2013	1	-1	N/A	-1	N/A
9/30/2013	1	-1	N/A	-1	N/A
6/30/2013	1	-1	N/A	-1	N/A
3/31/2013	1	-2	N/A	-1	N/A
12/31/2012	0	-2	N/A	-1	N/A

アナリストによる今後の成長予測

収入対貯蓄率: Insufficient data to determine if WFL's forecast earnings growth is above the savings rate (2%).

収益対市場: Insufficient data to determine if WFL's earnings are forecast to grow faster than the Australian market

高成長収益: Insufficient data to determine if WFL's earnings are expected to grow significantly over the next 3 years.

収益対市場: Insufficient data to determine if WFL's revenue is forecast to grow faster than the Australian market.

高い収益成長: Insufficient data to determine if WFL's revenue is forecast to grow faster than 20% per year.

一株当たり利益成長率予想

将来の株主資本利益率

将来のROE: Insufficient data to determine if WFL's Return on Equity is forecast to be high in 3 years time

Wellfully 将来の成長

Future 基準チェック /06

主要情報

今後の成長に関する最新情報

Recent updates

Wellfully Limited, Annual General Meeting, Apr 26, 2024

Wellfully Limited Announces Board Changes

Wellfully Limited Appoints John Forrester as Director

First half 2023 earnings released: AU$0.015 loss per share (vs AU$0.019 loss in 1H 2022)

Wellfully Limited Appoints David Wheeler as Non-Executive Director, Effective from 1 February 2023

Wellfully Limited Announces Step Down of Steven Schapera as Non-Executive Director, Effective 31 December 2022

Wellfully Limited (ASX:WFL) entered into a non-binding MOU to acquire The Brandbase from Capital D Management LLP for AUD 2.8 million.

Wellfully Limited (ASX:WFL) entered into a non-binding MOU to acquire The Brandbase from Capital D Management LLP for AUD 2.8 million.

Wellfully Limited Appoints Andy Wortlock as Non-Executive Director

Less than half of directors are independent

Wellfully Limited, Annual General Meeting, Nov 25, 2022

Full year 2022 earnings released: AU$0.031 loss per share (vs AU$0.041 loss in FY 2021)

Full year 2022 earnings released: AU$0.034 loss per share (vs AU$0.041 loss in FY 2021)

Wellfully Limited has completed a Follow-on Equity Offering in the amount of AUD 0.136528 million.

Wellfully Limited Announces Knee Patch Registered as A Medical Device

Wellfully Limited has completed a Follow-on Equity Offering in the amount of AUD 0.1 million.

Wellfully Limited announced that it expects to receive AUD 0.1 million in funding

Wellfully Limited has completed a Follow-on Equity Offering in the amount of AUD 0.13 million.

Wellfully Limited Announces Board Changes

Wellfully Limited Announces Swisswell Knee Patch Successfully Registered as Medical Device in the USA

Less than half of directors are independent

Less than half of directors are independent

Wellfully Limited Announces Board Changes

First half 2022 earnings: Revenues and EPS in line with analyst expectations

Independent Non-Executive Director Cameron Reynolds has left the company

Full year 2021 earnings released: AU$0.041 loss per share (vs AU$0.041 loss in FY 2020)

Full year 2021 earnings released: AU$0.041 loss per share (vs AU$0.041 loss in FY 2020)

Wellfully Limited announced that it expects to receive AUD 4.75 million in funding

Wellfully Limited has announced a Derivatives Offering in the amount of AUD 0.112307 million.

Wellfully Limited Announces Business & Operational Update

Wellfully Limited Completes Its Scheduled Release of 20 Launches in 20 Weeks for Its RÉDUIT Brand

Full year earnings released - AU$0.041 loss per share

Wellfully Limited Signs A Content Partnership for Its RÉDUIT Brand with Victoria Beckham

Wellfully Limited Agrees to Supply Terms For, and Launches its Réduit Brand with The Hut Group

Full year earnings released

業績と収益の成長予測

アナリストによる今後の成長予測

一株当たり利益成長率予想

将来の株主資本利益率

成長企業の発掘